Genprex, Inc. (NASDAQ:GNPX)
Industry: Biotechnology

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Current Quote*
Last: $0.240
Change: 0.000
Book: $2.212
Volume: 1,743,805

As Of: 07/01 16:08 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol GNPX

Graphs for GNPX


3 Month Graph


6 Month Graph


1 Year Graph